Cargando…

Does a Negative Rapid Diagnostic Test for Detection of Candida Bloodstream Infection Lead to Less Antifungal Use?

BACKGROUND: Candida species are the fourth leading cause of nosocomial bloodstream infections in the United States, however incidence is low and most patients who receive empiric treatment do not actually have candidemia. Unfortunately, detection, identification and susceptibility testing using stan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhowmick, Tanaya, Sharma, Rashi, Weinstein, Melvin, Narayanan, Navaneeth, Kirn, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630746/ http://dx.doi.org/10.1093/ofid/ofx163.1611

Ejemplares similares

2054. Physician Responses to Positive Rapid Diagnostic Tests for Candida Fungemia in the Absence of Concomitant Positive Blood Cultures
por: Bhowmick, Tanaya, et al.
Publicado: (2018)

Retrospective Study of Linezolid vs. Daptomycin for the Treatment of Vancomycin--resistant Enterococcal Bloodstream Infection
por: Rai, Rena, et al.
Publicado: (2017)

Impact of phenotypic rapid diagnostic assay on duration of empiric antibiotics for gram-negative bacteremia
por: Mohayya, Sana M., et al.
Publicado: (2023)

Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia
por: Narayanan, Navaneeth, et al.
Publicado: (2019)

1033. Effectiveness of a Physician-Driven Automated Antibiotic Time Out in the Setting of Gram-negative Bacteremia
por: Mohayya, Sana, et al.
Publicado: (2019)

Effectiveness of an Electronic Automated Antibiotic Time Out Alert in the Setting of Gram-Negative Bacteremia
por: Mohayya, Sana M., et al.
Publicado: (2021)

Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections
por: Bhowmick, Tanaya, et al.
Publicado: (2020)

Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting?
por: Vena, Antonio, et al.
Publicado: (2022)

Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal
por: Costa-de-Oliveira, Sofia, et al.
Publicado: (2020)

Evaluation of Candida bloodstream infection and antifungal utilization in a tertiary care hospital
por: Marins, Tatiana Aporta, et al.
Publicado: (2018)

Antifungal Susceptibilities of Bloodstream Isolates of Candida Species from Nine Hospitals in Korea: Application of New Antifungal Breakpoints and Relationship to Antifungal Usage
por: Won, Eun Jeong, et al.
Publicado: (2015)

Antifungal Susceptibility in Serum and Virulence Determinants of Candida Bloodstream Isolates from Hong Kong
por: Seneviratne, Chaminda J., et al.
Publicado: (2016)

Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey
por: Dagi, Hatice Turk, et al.
Publicado: (2016)

146. antifungal Susceptibility Patterns of candida Parapsilosis Bloodstream Isolates in the US, 2008–2018
por: Tesini, Brenda L, et al.
Publicado: (2020)

In Vitro Antifungal Activity of Manogepix and Other Antifungal Agents against South African Candida auris Isolates from Bloodstream Infections
por: Maphanga, Tsidiso G., et al.
Publicado: (2022)

Microdilution in vitro Antifungal Susceptibility Patterns of Candida Species, From Mild Cutaneous to Bloodstream Infections
por: Rezazadeh, Elham, et al.
Publicado: (2016)

Invasive Candida parapsilosis Bloodstream Infections in Children: The Antifungal Susceptibility, Clinical Characteristics and Impacts on Outcomes
por: Wang, Yao-Sheng, et al.
Publicado: (2023)

Species Distribution and Susceptibility to Azole Antifungals of Candida Bloodstream Isolates from Eight University Hospitals in Korea
por: Lee, Jin-Sol, et al.
Publicado: (2007)

Revisiting Species Distribution and Antifungal Susceptibility of Candida Bloodstream Isolates from Latin American Medical Centers
por: da Matta, Daniel Archimedes, et al.
Publicado: (2017)

A study on biofilm production and antifungal drug resistance among Candida species from vulvovaginal and bloodstream infections
por: Tulasidas, Sanyuktha, et al.
Publicado: (2018)

Antifungal Susceptibility to Amphotericin B, Fluconazole, Voriconazole, and Flucytosine in Candida Bloodstream Isolates from 15 Tertiary Hospitals in Korea
por: Jung, Sook-In, et al.
Publicado: (2012)

Impact of inappropriate antifungal therapy according to current susceptibility breakpoints on Candida bloodstream infection mortality, a retrospective analysis
por: González-Lara, María Fernanda, et al.
Publicado: (2017)

277. Identification and Antifungal Susceptibility of Candida Species Isolated from Bloodstream Infections Over a 14-Year Period
por: Kline, Ahnika, et al.
Publicado: (2019)

A clinical analysis of Candida tropicalis bloodstream infections associated with hematological diseases, and antifungal susceptibility: a retrospective survey
por: Yang, Beibei, et al.
Publicado: (2023)

Candida auris Bloodstream Infections in Russia
por: Barantsevich, Natalia E., et al.
Publicado: (2020)

P018 Susceptibility profile of Candida albicans causing bloodstream infections against azole antifungals over 5 years: A prospective observational study
por: Sharma, Megha, et al.
Publicado: (2022)

A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes
por: Rodriguez, Lourdes, et al.
Publicado: (2017)

Candida Bloodstream Infection: Changing Pattern of Occurrence and Antifungal Susceptibility over 10 Years in a Tertiary Care Saudi Hospital
por: Alkharashi, Nawaf, et al.
Publicado: (2019)

Nationwide Surveillance of Antifungal Resistance of Candida Bloodstream Isolates in South Korean Hospitals: Two Year Report from Kor-GLASS
por: Won, Eun Jeong, et al.
Publicado: (2022)

Clinical Outcomes of Patient Subgroups in the TANGO II Study
por: Bhowmick, Tanaya
Publicado: (2021)

Candida utilis catheter-related bloodstream infection
por: Scoppettuolo, Giancarlo, et al.
Publicado: (2014)

Echinocandin-resistant Candida tropicalis Bloodstream Infections
por: Sfeir, Maroun, et al.
Publicado: (2017)

Changing trends in epidemiology and antifungal susceptibility patterns of six bloodstream Candida species isolates over a 12-year period in Kuwait
por: Khan, Ziauddin, et al.
Publicado: (2019)

Systematic Evaluation of the Accelerate Pheno System for Susceptibility Testing of Gram-Negative Bacteria Isolated from Blood Cultures
por: Patel, Yera A., et al.
Publicado: (2021)

Candida Species Biofilms’ Antifungal Resistance
por: Silva, Sónia, et al.
Publicado: (2017)

Comparative Evaluation of Antifungal Efficacy of Five Root Canal Sealers against Clinical Isolates of Candida albicans: A Microbiological Study
por: Singh, Sameep, et al.
Publicado: (2020)

Linking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in Candida Pathogens
por: Sharma, Jehoshua, et al.
Publicado: (2019)

Epidemiological Characteristics, Antifungal Susceptibility, Risk Factors, and Outcomes of Candida Bloodstream Infection: A Ten-Year Surveillance in a Teaching Hospital in China
por: Qiao, Yan, et al.
Publicado: (2023)

Host response to Candida albicans bloodstream infection and sepsis
por: Duggan, Seána, et al.
Publicado: (2015)

Risk Factors Predicting Candida glabrata Bloodstream Infection
por: O’Halloran, Jane, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_l25f150dtlbglntco6jcrlaa54